Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

ClinicalTrials.gov ID: NCT07390474

Public ClinicalTrials.gov record NCT07390474. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 1:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

Study identification

NCT ID: NCT07390474
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Enrollment: 40 participants

Conditions and interventions

Conditions

Interventions

DV201P-RNA Biological
DV202B1-RNA Biological

Biological

Eligibility (public fields only)

Age range: 18 Years to 55 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 24, 2026
Primary completion: Dec 13, 2027
Completion: Dec 13, 2027
Last update posted: May 18, 2026

2026 – 2027

United States locations

U.S. sites: 7
U.S. states: 4
U.S. cities: 7

Facility	City	State	ZIP	Site status
The Ponce de Leon Center CRS	Atlanta	Georgia	30308	Not yet recruiting
The Hope Clinic of the Emory Vaccine Research Center; Emory University	Decatur	Georgia	30030	Recruiting
Beth Israel Deaconess Medical Center VCRS (BIDMC VCRS Site # 32077)	Boston	Massachusetts	02215	Not yet recruiting
Columbia P&S CRS	New York	New York	10032	Not yet recruiting
University of Rochester Vaccines to Prevent HIV Infection CRS	Rochester	New York	14642	Not yet recruiting
Penn Prevention CRS	Philadelphia	Pennsylvania	19104	Not yet recruiting
University of Pittsburgh CRS	Pittsburgh	Pennsylvania	15213	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07390474, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 18, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07390474 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →